Literature DB >> 9731921

Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan.

C S Wang1, T T Chang, P Chou.   

Abstract

This is a study of the differences in the risk factors for being either hepatitis B surface antigen positive [HBsAg(+)] or antibody to hepatitis C virus positive [Anti-HCV(+)] in A-Lein, a rural area in southern Taiwan, an area which also has a high hepatoma mortality rate. Three hundred eighty-five patients age > or =40 years participated in hepatoma screening at the A-Lein Community Health Center during 1995. Those who were HBsAg(-) and anti-HCV(-) or had coinfection of HBsAg(+) and anti-HCV(+) were excluded, leaving 293 patients: 109 HBsAg(+) and 184 anti-HCV(+). The anti-HCV(+) patients had a lower socioeconomic status (as defined by level of education and type of occupation) and were older than HBsAg(+) patients (P < 0.05). Those with higher alanine aminotransferase levels (ALT) also had a higher anti-HCV(+) to HBsAg(+) odds ratio (OR), and a dose response relationship was found, P < 0.0001. Anti-HCV(+) patients were more likely than HBsAg(+) patients to have a spouse who shared the infection, OR = 5.11; 95% CI, 2.30-11.28. Anti-HCV(+) patients were more likely than HBsAg(+) patients to have had blood transfusions (OR = 2.66; 95% CI, 1.20-5.89), frequent medical injections (OR = 2.64; 95% CI, 1.62-4.31), or injections by non-licensed medical providers (OR = 1.91; 95% CI, 1.18-3.09). Multiple logistic regression analysis showed that the significant factors for anti-HCV(+) patients vs. HBsAg(+) patients are drinking habit (OR = 3.45; 95% CI, 1.02-11.60), age (OR = 6.33; 95% CI, 2.93-13.68), and frequent medical injections (OR = 2.88; 95% CI, 1.65-5.03). The transmission of hepatitis C in A-Lein is closely related to low socioeconomic status, age, alcohol abuse, spouses being anti-HCV(+), and frequent medical injections, especially from non-licensed medical providers, including both pharmacists and those with no medical licensing whatsoever. These nonlicensed medical providers sometimes reuse needles to save money, which is a likely route of infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731921     DOI: 10.1016/s0895-4356(98)00060-2

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  7 in total

1.  Geographic variations of predominantly hepatitis C virus associated male hepatocellular carcinoma townships in Taiwan: identification of potential high HCV endemic areas.

Authors:  Wei-Wen Su; Chien-Hung Chen; Hans Hsienhong Lin; Sheng-Shun Yang; Ting-Tsung Chang; Ken-Sheng Cheng; Jaw-Ching Wu; Shun-Sheng Wu; Chuan-Mo Lee; Chi-Sin Changchien; Chien-Jen Chen; Jin-Chuan Sheu; Ding-Shinn Chen; Sheng-Nan Lu
Journal:  Hepatol Int       Date:  2009-08-07       Impact factor: 6.047

2.  Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.

Authors:  Hong Zhang; Shu Mei He; Jie Sun; ChunYan Wang; Yan Fang Jiang; Qing Gu; Xiang Wei Feng; Bing Du; Wei Wang; Xiao Dong Shi; Si Qi Zhang; Wan Yu Li; Jun Qi Niu
Journal:  Int J Med Sci       Date:  2011-03-25       Impact factor: 3.738

Review 3.  The epidemiology of hepatitis C virus in the Maghreb region: systematic review and meta-analyses.

Authors:  Fatima A Fadlalla; Yousra A Mohamoud; Ghina R Mumtaz; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

4.  Demographic and Urbanization Disparities of Liver Transplantation in Taiwan.

Authors:  Pei-Hung Wen; Chin-Li Lu; Carol Strong; Yih-Jyh Lin; Yao-Li Chen; Chung-Yi Li; Chiang-Chin Tsai
Journal:  Int J Environ Res Public Health       Date:  2018-01-23       Impact factor: 3.390

5.  Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan.

Authors:  Pei-Chien Tsai; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Meng-Hsuan Hsieh; Jeng-Fu Yang; Po-Yao Hsu; Po-Cheng Liang; Yi-Hung Lin; Tyng Yuan Jang; Ming-Yen Hsieh; Chia-Yen Dai; Zu-Yau Lin; Shinn-Chern Chen; Jee-Fu Huang; Ming-Lung Yu; Wan-Long Chuang; Wen-Yu Chang
Journal:  BMJ Open       Date:  2021-03-15       Impact factor: 2.692

6.  Towards a safe hospital: hepatitis C in-hospital micro-elimination program (HCV-HELP study).

Authors:  Jee-Fu Huang; Ming-Yen Hsieh; Yu-Ju Wei; Jen-Yu Hung; Hsuan-Ti Huang; Ching-I Huang; Ming-Lun Yeh; Chung-Feng Huang; Tyng-Yuan Jang; Po-Yao Hsu; Po-Cheng Liang; Chia-Yen Dai; Zu-Yau Lin; Ming-Lung Yu; Wan-Long Chuang
Journal:  Hepatol Int       Date:  2021-11-30       Impact factor: 9.029

7.  Hepatitis B surface antigen prevalence among 12,393 rural women of childbearing age in Hainan Province, China: a cross-sectional study.

Authors:  Yu Zhang; Weiming Fang; Lichun Fan; Xiaohui Gao; Yan Guo; Wenming Huang; Yukai Du
Journal:  Virol J       Date:  2013-01-18       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.